Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12219084
[patent_doc_number] => 20180057444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'AMINATION AND HYDROXYLATION OF ARYLMETAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/659320
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 31535
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15659320
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/659320 | Amination and hydroxylation of arylmetal compounds | Jul 24, 2017 | Issued |
Array
(
[id] => 16800163
[patent_doc_number] => 10995084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-04
[patent_title] => Pyrrolidine derivative
[patent_app_type] => utility
[patent_app_number] => 16/317934
[patent_app_country] => US
[patent_app_date] => 2017-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55954
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317934
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317934 | Pyrrolidine derivative | Jul 19, 2017 | Issued |
Array
(
[id] => 14867871
[patent_doc_number] => 20190284177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => HETEROAROMATIC MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA
[patent_app_type] => utility
[patent_app_number] => 16/317655
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30585
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317655
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317655 | Heteroaromatic modulators of the retinoid-related orphan receptor gamma | Jul 10, 2017 | Issued |
Array
(
[id] => 12543051
[patent_doc_number] => 10010551
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Pyrimidinyl-diazospiro compounds
[patent_app_type] => utility
[patent_app_number] => 15/646552
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14537
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15646552
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/646552 | Pyrimidinyl-diazospiro compounds | Jul 10, 2017 | Issued |
Array
(
[id] => 14993515
[patent_doc_number] => 20190315715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => NOVEL PYRIMIDINE CARBOXAMIDES AS INHIBITORS OF VANIN-1 ENZYME
[patent_app_type] => utility
[patent_app_number] => 16/316688
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316688
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316688 | Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme | Jul 6, 2017 | Issued |
Array
(
[id] => 16125867
[patent_doc_number] => 10696674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Spirolactams as inhibitors of ROCK
[patent_app_type] => utility
[patent_app_number] => 16/315678
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24522
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 581
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315678 | Spirolactams as inhibitors of ROCK | Jul 5, 2017 | Issued |
Array
(
[id] => 14774949
[patent_doc_number] => 20190262372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => COMPOUNDS,COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/315472
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315472
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315472 | Compounds,Compositions, and methods for the treatment of disease | Jul 5, 2017 | Issued |
Array
(
[id] => 16275524
[patent_doc_number] => 10758531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Regimens and compositions for treating HIV infections and AIDS
[patent_app_type] => utility
[patent_app_number] => 16/308844
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6325
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308844
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308844 | Regimens and compositions for treating HIV infections and AIDS | Jun 29, 2017 | Issued |
Array
(
[id] => 14501001
[patent_doc_number] => 20190194155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => PROCESS OF PREPARING A PEPTIDE EPOXYKETONE IMMUNOPROTEASOME INHIBITOR, AND PRECURSORS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/312688
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -64
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312688
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312688 | Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof | Jun 28, 2017 | Issued |
Array
(
[id] => 11993901
[patent_doc_number] => 20170298054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY'
[patent_app_type] => utility
[patent_app_number] => 15/637833
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 157449
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15637833
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/637833 | Compositions and methods for inhibition of the JAK pathway | Jun 28, 2017 | Issued |
Array
(
[id] => 13717043
[patent_doc_number] => 20170369476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => 2,4-DIAMINO-PYRIMIDINE COMPOUNDS AND METHOD FOR MAKING AND USING THE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/633258
[patent_app_country] => US
[patent_app_date] => 2017-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15633258
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/633258 | 2,4-diamino-pyrimidine compounds and method for making and using the compounds | Jun 25, 2017 | Issued |
Array
(
[id] => 11986677
[patent_doc_number] => 20170290833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'SOLID STATE FORMS OF A QUINAZOLINE DERIVATIVE AND ITS USE AS A BRAF INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/632248
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 10971
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15632248
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/632248 | Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor | Jun 22, 2017 | Issued |
Array
(
[id] => 14652511
[patent_doc_number] => 20190233384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/312627
[patent_app_country] => US
[patent_app_date] => 2017-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312627
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312627 | Anti-infective heterocyclic compounds and uses thereof | Jun 21, 2017 | Issued |
Array
(
[id] => 14715417
[patent_doc_number] => 20190248772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => TYROSINE KINASE INHIBITOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/333050
[patent_app_country] => US
[patent_app_date] => 2017-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333050
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333050 | Tyrosine kinase inhibitor and application thereof | Jun 21, 2017 | Issued |
Array
(
[id] => 17162951
[patent_doc_number] => 11149038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Synthetic co-crystals of anhydrous guanine and process for preparing the same
[patent_app_type] => utility
[patent_app_number] => 16/311700
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 20
[patent_no_of_words] => 9883
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311700
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311700 | Synthetic co-crystals of anhydrous guanine and process for preparing the same | Jun 20, 2017 | Issued |
Array
(
[id] => 14467639
[patent_doc_number] => 20190185462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => 3-ARYL- HETEROARYL SUBSTITUTED 5-TRIFLUOROMETHYL OXADIAZOLES AS HISTONEDEACETYLASE 6 (HDAC6) INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/309390
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309390 | 3-aryl- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histonedeacetylase 6 (HDAC6) inhibitors | Jun 18, 2017 | Issued |
Array
(
[id] => 15784823
[patent_doc_number] => 10626118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Pyrrolopyrimidine crystal for preparing JAK inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/310369
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 9114
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310369
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310369 | Pyrrolopyrimidine crystal for preparing JAK inhibitor | Jun 14, 2017 | Issued |
Array
(
[id] => 16290065
[patent_doc_number] => 10766901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Preparation method for chiral pyrrolopyrimidine compound
[patent_app_type] => utility
[patent_app_number] => 16/309882
[patent_app_country] => US
[patent_app_date] => 2017-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8768
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309882
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309882 | Preparation method for chiral pyrrolopyrimidine compound | Jun 14, 2017 | Issued |
Array
(
[id] => 12675625
[patent_doc_number] => 20180117041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => LIVER X RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/618297
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618297
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/618297 | LIVER X RECEPTOR MODULATORS | Jun 8, 2017 | Abandoned |
Array
(
[id] => 11963495
[patent_doc_number] => 20170267647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 15/616039
[patent_app_country] => US
[patent_app_date] => 2017-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96068
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15616039
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/616039 | Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith | Jun 6, 2017 | Issued |